MNOV
MNOV
NASDAQ · Biotechnology

Medicinova Inc

$2.10
-0.48 (-18.60%)
As of Sep 28, 10:25 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +1,257.1% upside
Low Target $17.57
Average Target $28.50
High Target $41.49
Current Price $2.10
Current
$2.10
Target
$28.50
$17.57 $28.50 avg $41.49
Scenario Analysis
Bear Case
$17.57
736.7%
Low target
Base Case
$28.50
+1,257.1%
Avg target
Bull Case
$41.49
+1,875.7%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$3.90
-46.2% from high
52-Week Low
$1.17
+79.8% from low
Target vs 52W High
$28.50
+630.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%